THE ATTENTION DEFICIT DILEMMA AND OUR CHILDREN

"Peter Bowditch" THE LIAR AND wrote:
"Jan Drew" wrote:


"John Palmer" wrote in message
. ..
On Mon, 12 Mar 2007 11:33:40 GMT, "Jeff" wrote:


That's true of any drugs. I have read one of Peter Breggin's books.
He
clearly doesn't, IMHO, understand ADHD.

ROTFLOL.

He tells it like it is.

He tells it like he sees it. And what he sees is the royalties he gets
when
his books sell.

He does neither. He's a liar.

GOD BLESS DR BREGGIN.


GOD BLESS DR BREGGIN.

http://www.breggin.com/courtfiling.pbreggin.2006.html


Suppressed Paxil Suicide Data Released


Expert Calls for Drug Companies to Publish Safety and Efficacy Data


February 27, 2006, Ithaca, New York


Ethical Human Psychology and Psychiatry (EHPP) has published an
excerpt from a previously sealed product liability report against Glaxo
SmithKline (GSK). The medical expert report documents how the company
systematically hid and manipulated data concerning Paxil-induced suicidality
in depressed adults. The number of suicide attempts on the antidepressant
Paxil was under-reported and the number of suicide attempts on placebo was
inflated.


The entire product liability report is reproduced on www.breggin.com.
It further documents how GSK hid the incidence of Paxil-induced akathisia
(agitation with hyperactivity) and stimulation. Akathisia and stimulation
are risks factors for suicidality and violence. The product liability
report also cites previously unreleased FDA correspondence critical of GSK's
marketing and advertising tactics in regard to Paxil.


The excerpts were published as part of a Special Report by Peter R.
Breggin, M.D. in Ethical Human Psychology and Psychiatry (Volume 8, Spring
2006, pp. 77-84). Dr. Breggin's original psychiatric expert report was
written for Lacuzong v. GSK and signed as an affidavit in California on July
21, 2001. It was based on a three-day examination of GSK's sealed files at
the company headquarters.


The Lacuzong case was brought by the widow of a man who drowned their
two children and himself in a tub after taking Paxil for three days. The
attorney was Don Farber of San Rafael, California.


The Lacuzong case was "resolved" to the satisfaction of the family;
the drug company denied all allegations. At GSK's insistence, Dr. Breggin's
report remained sealed. However, in a more recent case against the company,
Moffett v. Glaxo SmithKline, the United States District Court for the South
District of Mississippi, the report was filed in the public record and is
now available at the court as well as on www.breggin.com.


The FDA has recently issued a preliminary warning that newer
antidepressants like Paxil may cause increased suicidality in adult
patients. The FDA is planning further scientific review but, as this special
report indicates, drug companies do not always reveal critical data to the
agency.


Dr. Breggin stated, "The drug companies settle almost all legal cases
brought against them in order to seal incriminating scientific data. This
deprives the FDA, medical profession and public of critical information on
drug safety and efficacy. The publication of a previously sealed medical
expert report is a rare event-the first in my experience. The law should be
changed to require drug companies to publish all of the safety and efficacy
data they generate in regard to their drug products."


http://www.breggin.com/


Bibliography of Peter R. Breggin, M.D.


The bibliography is divided into the following three sections:
I. 19 professional books
II. 30 peer-reviewed articles
III. Many other professional publications such as articles, reviews,
letters, and book chapters.


I. PROFESSIONAL BOOKS


1. College Students in a Mental Hospital: Contribution to the Social
Rehabilitation of the Mentally Ill. New York, Grune & Stratton, 1962
(jointly authored by Carter Umbarger, James Dalsimer, Andrew Morrison, and
Peter Breggin).


2. Electroshock: Its Brain-Disabling Effects. New York, Springer
Publishing Company, 1979. Translated into French, German &
Italian. Behavioral Sciences Book Club selection.


3. The Psychology of Freedom: Liberty and Love as a Way of Life .
Buffalo, Prometheus Books, 1980.


4. Psychiatric Drugs: Hazards to the Brain. New York, Springer
Publishing Company, 1983.


5. Toxic Psychiatry: Why Therapy, Empathy and Love Must Replace the Drugs,
Electroshock and Biochemical Theories of the "New Psychiatry" New York,
St. Martin's Press, 1991. Psychotherapy
Book Club selection. Special English edition with an introduction by
Dorothy Rowe. Harper/Collins, London, 1993. St. Martin's paperback, 1994.
Also translated into German.


6. Beyond Conflict: From Self-Help and Psychotherapy to Peacemaking New
York, St. Martin's Press (scholarly division), 1992. St. Martin's
paperback, 1995.


7. Talking Back to Prozac (Coauthored by Ginger Breggin) New York: St.
Martin's Press, 1994. St. Martin's Press, 1994. St. Martin's paperback,
1994.


8. Psychosocial Approaches to Deeply Disturbed Patients. Senior Editor,
Peter Breggin. Co-editor, E. Mark Stern. New York: Haworth Press. Also
published as The Psychotherapy Patient, Volume 9, Numbers 3/4, 1996.


9. The War Against Children: How the Drugs, Programs, and Theories of the
Psychiatric Establishment Are Threatening America's Children with a Medical
"Cure" for Violence. Coauthored by Ginger Breggin. New York, St. Martin's
Press, 1994.


10. Brain-Disabling Treatments in Psychiatry. New York: Springer Publishing
Company, 1997.


11. The Heart of Being Helpful: Empathy and the Creation of a Healing
Presence. New York: Springer Publishing Company, 1997.


12. Talking Back to Ritalin. (first edition) Monroe, Maine: Common Courage
Press, 1998.


13. The War Against Children of Color. (revised edition). Coauthored by
Ginger Breggin. Monroe, Maine: Common Courage Press, 1998.


14. Your Drug May Be Your Problem: How and Why To Stop Taking Psychiatric
Medications. Co-authored by David Cohen, Ph.D. Reading, MA: Perseus Books,
1999.


15. Reclaiming Our Children: A Healing Solution for a National In Crisis.
Cambridge, MA: Perseus Books, 2000.


16. Talking Back to Ritalin. (revised edition). Cambridge, MA: Perseus
Books, 2000.


17. The Antidepressant Fact Book. Cambridge, MA: Perseus Books, 2001


18. Dimensions of Empathic Therapy. Co-edited by Ginger Breggin and Fred
Bemak, Ed.D. New York: Springer Publishing Company, 2002.


19. The Ritalin Fact Book. Cambridge, MA: Perseus Books, 2002.


II. PEER REVIEWED ARTICLES


1. "The Psychophysiology of Anxiety." Journal of Nervous Mental Diseases
139:558-568, 1964.


2. "Coercion of Voluntary Patients in an Open Hospital." Archives of
General Psychiatry 10:173-181, 1964. Reprinted with a new introduction in
Edwards, R.B. (ed): Psychiatry and Ethics. Buffalo, Prometheus Books, 1982,
and in Edwards, R.B. (ed): Ethics of Psychiatry. Amherst, New York,
Prometheus Books, 1997.


3. "The Sedative-like Effect of Epinephrine." Archives of General
Psychiatry 12:255-259, 1965.


4. "Psychotherapy as Applied Ethics." Psychiatry 34:59-75, 1971.


5. "Therapy As Applied Utopian Politics." Mental Health and Society
1:129-146, 1974.


6. "Psychiatry and Psychotherapy as Political Processes." American Journal
of Psychotherapy 29:369-382, 1975.


7. "Madness is a Failure of Free Will; Therapy Too Often Encourages It."
Psychiatric Quarterly 53:61-68, 1981.
Originally published (in French) in Verdiglione A (ed): La Folie Dans La
Psychoanalyse. Paris, Payot, 1977.


8. "Electroshock Therapy and Brain Damage: The Acute Organic Brain Syndrome
as Treatment." Behavior and Brain Sciences 7:24-25, 1984 (commentary).


9. "Neuropathology and Cognitive Dysfunction from ECT." Psychopharmacology
Bulletin 22:476-479, 1986.


10. "Ellettroshock: Tra Rischioiatrogeno e Mito Terapeutico." (P. Breggin
and G. de Girolamo) Quaderni Italiani di Psychiatrica 6:497-540, 1987.


11. "The Three Dynamics of Human Progress: A Unified Theory Applicable to
Individuals, Institutions and Society." Review of Existential Psychology
and Psychiatry 21Nos. 1-3)97-123, 1988-89.


12. "Precious the Crow." Voices (Journal of the American Academy of
Psychotherapists) 23:32-42, Summer, 1987.


13. "Brain Damage, Dementia and Persistent Cognitive Dysfunction Associated
with Neuroleptic Drugs: Evidence, Etiology, Implications." Journal of Mind
Behavior 11:425-464, 1990.


14. "Psychotherapy in the Shadow of the Psycho-Pharmaceutical Complex,"
Voices (journal of the American Academy of Psychotherapists) 27:15-21, 1991


15. "A Case of Fluoxetine-induced Stimulant Side Effects with Suicidal
Ideation Associated with a Possible Withdrawal Syndrome ("Crashing")."
International Journal of Risk & Safety in Medicine 3:325-328, 1992


16. "Parallels Between Neuroleptic Effects and Lethargic Encephalitis: The
Production of Dyskinesias and Cognitive disorders." Brain and Cognition
23:8-27, 1993.


17. "A Biomedical Programme for Urban Violence Control in the US: The
Dangers of Psychiatric Social Control." (Peter Breggin and Ginger Ross
Breggin). Changes: An International Journal of Psychology and Psychotherapy
11, No. 1 (March):59-71, 1993.


18. "Psychiatry's Role in the Holocaust." International Journal of Risk and
Safety in Medicine 4:133-148, 1993. Adapted from a paper delivered at
"Medical Science Without Compassion" in Cologne, Germany and published in
the conference proceedings.


19. "Should the Use of Neuroleptics Be Severely Limited?" Changes: An
International Journal of Psychology and Psychotherapy 14:62-66 March 1996.


20. "The Hazards of Treating 'Attention-Deficit/Hyperactivity Disorder' with
Methylphenidate (Ritalin)" (Coauthored by Ginger Breggin) Journal of
College Student Psychotherapy 10:55-72, 1996.


21. "Psychotherapy in Emotional Crises without Resort to Psychiatric
Medication." The Humanistic Psychologist 25:2-14, 1998.


22. "Analysis of Adverse Behavioral Effects of Benzodiazepines with a
Discussion of Drawing Scientific Conclusions from the FDA's Spontaneous
Reporting System." Journal of Mind and Behavior 19:21-50, 1998.


23. "Electroshock: Scientific, ethical, and political issues."
International Journal of Risk & Safety In Medicine 11:5-40, 1998.


24. "Psychostimulants in the treatment of children diagnosed with ADHD: Part
I-Acute risks and psychological effects." Ethical Human Sciences and
Services 1:13-33, 1999.


25. "Psychostimulants in the treatment of children diagnosed with ADHD: Part
II-Adverse effects on brain and behavior." Ethical Human Sciences and
Services 1:213-241, 1999.


26. "Psychostimulants in the treatment of children diagnosed with ADHD:
Risks and mechanism of action." International Journal of Risk and Safety in
Medicine, 12 (1), 3-35, 1999.
(Simultaneously published version of #'s 24 and 25)


27. "What psychologists and psychotherapists need to know about ADHD and
stimulants." Changes: An International Journal of Psychology and
Psychotherapy 18:13-23, Spring 2000


28. "The NIMH multimodal study of treatment for
attention-deficit/hyperactivity disorder: A critical analysis."
International Journal of Risk and Safety in Medicine 13:15-22, 2000


29. "Empathic self-transformation and love in individual and family
therapy." Humanistic Psychologist, 27:267-282, 1999.


30. "Fluvoxamine as a cause of stimulation, mania, and aggression with a
critical analysis of the FDA-approved label." International Journal of Risk
and Safety in Medicine, 2002, in press.


III. OTHER ARTICLES, REPORTS, LETTERS, AND BOOK CHAPTERS


"Schizophrenia as nondependency." Hutchings Journal (Department of
Psychiatry, State University of New York, Upstate Medical Center, Syracuse).
Vol. l, No. 2, pp. 1-3, December 1962.


"The college student and the mental patient." In College Student Companion
Program: Contribution to the Social Rehabilitation of the Mentally Ill.
Rockville, Maryland; National Institute of Mental Health, 1962.


"The psychophysiology of anxiety applied to the effect of adrenaline on rat
behavior." Submitted in partial fulfillment of the requirements for the
degree of Doctor of Medicine, Western Reserve School of Medicine, 1962.
Portions published in the Journal of Nervous and Mental Disease (1964) and
the Archives of General Psychiatry (1965) (see list of peer reviewed
articles).


"The borderland of criminal justice." (book review and commentary) Journal
of Nervous and Mental Diseases 141:387-394, 1965.


"Lobotomy is still bad medicine." Medical Opinion 8:3236, 1972.


"Lobotomies: an alert." (letter) American Journal of Psychiatry 129:98-99,
1972.


"The politics of therapy." M/H (Mental Health) 56:9-13,1972.


"Lobotomy." (co-authored by Daniel Greenberg). Science and Government
Policy, March 15, 1972, Volume II, No. 2, p. !.


"Psychosurgery." (letter) Journal of the American Medical Association
226:1121, 1973.


"The second wave of psychosurgery." M/H (Mental Health) 57:10-13, 1973.


"Psychiatric oppression of prisoners." (coauthored by PL Breggin).
Psychiatric Opinion, June, 1974


"Psychosurgery for political purposes." Duquesne Law Review 13:841-862,
1975.


"Psychosurgery for the control of violence: a critical review." Chapter IV
in Fields W, Sweet W (eds): Neural Bases of Violence and Aggression . St.
Louis, Warren H. Green Publisher, 1975.


"If psychosurgery is wrong in principle...?" Psychiatric Opinion ,
November/December 1977.


"La seconde vague. A propos de la lobotomie." In Verdiglione A (ed): La
Folie II: Actes Due Colloque De Milan, 1976. Paris, Giangiacomo
Feltrinelli, 1977.


"Brain-disabling therapies." In Valenstein E (ed): The Psychosurgery
Debate. San Francisco, WH Freeman, 1980.


"Disabling the brain with electroshock." In Dongier M, Wittkower ED (eds):
Divergent Views in Psychiatry. Hagerstown, Maryland; Harper and Row, 1981.


"Psychosurgery as brain-disabling therapy." In Dongier M, Wittkower D
(eds): Divergent Views in Psychiatry. Hagerstown, Maryland; Harper and Row,
1981.


"Compulsion as a spiritual disorder." (co-authored by J. Kasmir) Newsletter
of the Washington Branch of the Association for Humanistic Psychology .
Washington, D.C., October, 1982.


"The return of lobotomy and psychosurgery." Reprinted with a new
introduction in Edwards RB (ed): Psychiatry and Ethics. Buffalo, Prometheus
Books, 1982. Originally published in the Congressional Record , February
24, 1972, E1602-E1612. First reprinted in Quality of Health Care-Human
Experimentation: Hearings Before Senator Edward Kennedy's Subcommittee on
Health, US Senate, Washington, D.C., US Government Printing Office, 1973.


"Testimony on electroshock treatment" before the Respiratory and Nervous
System Devices Panel, Volume II, Food and Drug Administration, Department of
Health and Human Services, Washington, DC, November 4, 1982.


"What cost leukotomy?" (letter) American Journal of Psychiatry 140:1101,
1983.


"Iatrogenic helplessness in authoritarian psychiatry." In Morgan RF (ed):
The Iatrogenics Handbook. Toronto, IPI Publishing Company, 1983.


"Neuropathology and cognitive dysfunction from ECT." Presented at the
Consensus Development Conference on Electroconvulsive Therapy, sponsored by
NIMH and NIH, 1985.


"Brain damage from nondominant ECT." (letter) American Journal Psychiatry
143:1320-1, 1986.


"Workshop on medication." In CSP: Choices and Challenges. Proceedings of
the Seventh National Conference of the Community Support Program of the
National Institute of Mental Health, 1985. U.S. Department of Health and
Human Services, National Institute of Mental Health, Rockville, Maryland
1986, pp. 92-95.


"Point-Counterpoint: Is electroconvulsive therapy outmoded?" Physicians
Weekly April 21, 1986.


"Sex and love: sexual dysfunction as a spiritual disorder." In Shelp EE
(ed): Sexuality and Medicine. Boston, D. Reidel, 1987.


"A hierarchy of values for evaluating human progress on an individual,
institutional and societal basis," in Kollenda K (ed): Ethical Individualism
and Organizations . New York, Praeger, 1988.


"Debate over euthanasia termed reminiscent of pre-Nazi Germany," Clinical
Psychiatry News, December 1988.


"Addiction to neuroleptics?" American Journal of Psychiatry 146:560, 1989


"Addiction to neuroleptics: Dr. Breggin Replies." American Journal
Psychiatry 146:1240, 1989


"The scapegoating of American children." Rights Tenet, March, 1990.
Reprinted from the Wall Street Journal, November 7, 1989.


"Cingulotomy rightfully abandoned." [letter] The Psychiatric Times , May
1990, p. 8


"The homeless mentally ill." (coauthored by M. Weinberger and P. Breggin)
American Journal of Psychiatry 148:600-601, 1991.


"San Francisco Board of Supervisors passes resolution against shock."
Rights Tenet, Spring 1991.


"More on the California shock controversy." Rights Tenet, Summer 1991.


"The facts about Clozapine (Clozaril)." Rights Tenet, Autumn 1991.


"Feminist paradigms and conflict resolution." (Co-authored by Ginger
Ross-Breggin and Peter Breggin). ICAR Newsletter (Institute for Conflict
Analysis and Resolution, George Mason University) Spring 1992.


"The President's sleeping pill and its makers" (letter). New York Times,
February 11, 1992.


"How and why psychiatry became a death machine [in Nazi Germany]." In
Roland, C., Friedlander, H. and Muller-Hill, B. (Eds.): Medical Science
Without Compassion. Arbeitspapiere-Atti-Proceedings. No. 11. Hamburger
Stiftung fur Sozialgeschichte des 20. Jahrhunderts. Hamburg, May 1992.


"The return of ECT." Readings: A Journal of Reviews and Commentary in Mental
Health, 3 (March, #1), 12-17, 1992.


"Prozac, suicide and violence: An analysis with reports from the Prozac
Survivors Support Group, Inc." Rights Tenet, Winter/Spring 1992.


"The 'Violence Initiative'-- A racist biomedical program for social
control." Rights Tenet, Summer 1992.


"U.S. Government asks, 'Are black people genetically violent?'" (co-authored
by Ginger Breggin). Rights Tenet, Winter/Spring 1992.


"The Federal Violence Initiative: Threats to black children (and others)."
(Coauthored by Ginger Breggin). Psych Discourse (newsjournal of the
Association of Black Psychologists) 24, No. 4 (April):8-11, 1993.


"Psychiatry doesn't cure unhappiness." (letter) New York Time s, September
11, 1993, p. A20.


"The FDA--More harm than good?" Rights Tenet, Summer 1993.


"Psychogate: Eli Lilly buys justice for itself." Rights Tenet , Autumn
1993.


"Children First." Rights Tenet, Winter 1993-94.


"Talking back to Prozac." Psychology Today, July/August 1994, p. 46.


"Prozac story misleading." (letter) APA Monitor (Newspaper of the American
Psychological Association), July 1994, p. 3-4


"Should the use of neuroleptics be severely limited? Yes." In S. A. Kirk
and Susan D. Einbinder P (ed): Controversial Issues in Mental Health .
Boston: Allyan and Bacon, 1994, pp. 146-152.


"Let's not 'treat' the problem of homelessness with drugs." (letter) New
York Times, June 28, 1994, p. A16


"Genetics and crime: Violence and the danger of psychiatric social control."
(Coauthored by Ginger Ross Breggin). 21st Century Afro Review , Fall 1994,
pp. 41-62.


"The Federal Violence Initiative comes to Chicago." Rights Tenet , Spring
1994.


"Talking back to Prozac." Rights Tenet, Summer 1994.


"Joe McCarthy lives!" [About the PR tactics of Eli Lilly] Rights Tenet,
Autumn 1994


"Encephalitis Lethargica." [letter]. Journal of Neuropsychiatry , 7 (3),
p. 387, summer 1995.


"Prozac 'hazardous' to children." (letter) Clinical Psychiatry News,
September 1995, p. 11


"Drugging our children won't cure the problems in schools." Insight
[magazine of the Washington Times] August 14, 1995, p. 18-21.


"Psychiatry doesn't help mental health cause." (letter) New York Times,
March 9, 1995, p. A24


"On the couch, culture affects all." (letter) New York Times , December 8,
1995, p. A30


"Future development of neuroleptic medications: A report to the FDA."
Rights Tenet, Fall 1995


"Campaigns against racist federal programs by the Center for the Study of
Psychiatry and Psychology." Journal of African American Men 1:No. 3, 3-22.
Winter 1995/96.


"Prescription privileges." (letter) APA Monitor (newspaper of the American
Psychological Association), March 1996, p. 49.


"The FDA was agitated over Halcion." (letter). Business Week , July 18,
1996.


"Shock treatment III: Resistance in the 1980s." Chapter 4 in Morgan R (Ed):
Electric Shock. Toronto, IPI Publishing, 1985. Republished in Morgan R
(Ed): Electroshock: The Case Against. Morgan Foundation Publishing:
International Published Innovations, Greenville, CA 1997


"Spearheading a transformation." Introduction to P. Breggin & E. M. Stern
(eds): Psychosocial Approaches to Deeply Disturbed Patients . New York:
Haworth Press, 1996.


"Whose attention disorder does Ritalin treat?" (letter). New York Times,
May 20, 1996, p. A14.


"Talking back to Eli Lilly." [Guest Commentary] Sacramento News & Review,
June 13, 1996


"No, don't relax ban" [critique of new FDA rules permitting involuntary
medical experimentation]. (letter). New York Times, November 6, 1996, p.
A6.


Psychotherapy in emotional crises without resort to psychiatric medication."
The Humanistic Psychologist, 25, 2-14, 1998.


"Neuroleptic warning" [in regard to clozapine-induced brain damage in
children]. (letter) Clinical Psychiatry News, March 1998, p. 8.


"Recent FDA decision raises ethical issues in drug research on children."
ICSPP News (International Center for the Study of Psychiatry and
Psychology), Spring/Summer, 1998, p. 3.


"Upcoming government conference on ADHD and Psychostimulants asks wrong
questions." ICSPP News (International Center for the Study of Psychiatry and
Psychology), Spring/Summer, 1998, p. 4.


"Background paper: Details revealed about dangerous federally funded NYC
experiments on children." [No byline] ICSPP News (International Center for
the Study of Psychiatry and Psychology), Spring/Summer, 1998, p. 13.


"Does clozapine treatment cause brain damage?" (1998, September) (letter)
Archives of General Psychiatry 55:845.


"Risks and mechanism of action of stimulants." (1998) In NIH Consensus
Development Conference: Diagnosis and Treatment of Attention Deficit
Hyperactivity Disorder: Program and Abstracts, pp. 105-12. Rockville, MD:
National Institutes of Health.


"Interview with Peter R. Breggin, M.D., author of Talking Back to Ritalin."
Corporate Crime Reporter, 12 (16), April 20, 1998.


"Psychostimulant effects on children: A primer for school psychologists and
counselors." (1998, December) Communique' (Newspaper of NASP--National
Association of School Psychologists), pp. 8-9.


"To love them is to drug them?" (February, 1999). Dr. Laura Perspective
[magazine published by Dr. Laura Schlessinger], pp. 8-9, ff.


"Foreword" in Stein, D.B. (1999). Ritalin is not the answer. San Francisco,
Jossey-Bass, pp. ix-xii.


"Foreword" in Vontress, C.E., Johnson, J.A., and Epp, L.R. (1999).
Cross-cultural counseling: A case book. Alexandria, Virginia, American
Counseling Association, pp. xi-xii.


"Prozac pedagogy." (letter). California Lawyer, March 15, 1999, p. 15


"Breaking news that Eric Harris was taking Luvox at the time of the
Littleton Murders." Press Release. International Center for the Study of
Psychiatry and Psychology, Bethesda, Maryland, April 30, 1999..


"Treatment of attention-deficit/hyperactivity disorder." (1999, April 28).
[letter] Vol. 281, No. 16. Journal of the American Medical Association, pp.
1490-1.


"From the editor-in-chief: The need for 'ethical' human sciences and
services." (1999, spring.) Ethical Human Sciences and Services, 1, 3-6.


"NIH consensus report highlights controversy surrounding ADHD diagnosis and
stimulant treatment." (1999, spring). Unsigned news commentary. Ethical
Human Sciences and Services, 1, 9-11.


"National Institute of Mental Health fails in its latest effort to push
Ritalin on America's children." Unsigned report from ICSPP. The Rights
Tenet (Summer 1999), pp. 4-5.


"Your drug may be your problem." Commentary. Washington Times , Sunday,
October 24, 1999, p. B5.


"Don't let 'experts' parent your children." Op Ed Column. USA Today.
Monday, February 28, 2000, p. 19A..


"A critical analysis of the NIMH multimodal treatment study for
Attention-Deficit Hyperactivity Disorder (the MTA study)." Ethical Human
Sciences and Services, 2, 63-72, 2000.


"A dangerous assignment." In Howard Rosenthal (Ed.). Favorite Counseling
and Therapy Homework Assignments: Leading Therapist Shares their Most
Creative Strategies, pp. 58-59. Philadelphia: Brunner Routledge, 2001.


"Neurotoxicants threaten childhood development." (letter). Psychiatric
Times, July 2001, p. 8.


"Confirming the hazards of stimulant drug treatment." (2001) Guest
editorial. International Journal of Risk & Safety in Medicine , 17,
199-200.


"Psychiatry's reliance on coercion." (2000) Editorial. Ethical Human
Sciences and Services. 2:115-118.


"Empowering social work in the era of biological psychiatry." (2001) The
Ephraim Lisansky lecture of the University of Maryland School of Social
Work. Ethical Human Sciences and Services. 3:197-206.


"MTA study [NIMH clinical trials on stimulants for ADHD] has flaws."
(letter) (2001) Archives of General Psychiatry, 58, 1184.



--
Peter Bowditch

snip advertisement for himself

"Mark Probert" wrote in message
newsjxJh.8793$t8.4001@trndny02...
Peter Bowditch wrote:
" " @sbcglobal.net wrote:

See Mark lie again........

"Peter Bowditch" wrote in message
...
"Jan Drew" wrote:

"Mark Probert" wrote in message
news:XxeJh.7517$t8.2836@trndny02...
Jeff wrote:
"Mark Probert" wrote in message
news:81eJh.4039$0W5.287@trndny05...
...

What makes one group who calls themselves "Christian" more "Christian"
than another group?
Caring
For all, even the homeless?

Enough to share??


The anwer is NO he did not.

"jandew6" wrote:


"Peter Bowditch" wrote :
"Jan Drew" wrote:



snip unsubstantiated defamation
--
Peter Bowditch

Typical liar.

snip unsubstantiated defamation
--
Peter Bowditch aa #2243
The Millenium Project http://www.ratbags.com/rsoles
Australian Council Against Health Fraud http://www.acahf.org.au
Australian Skeptics http://www.skeptics.com.au
To email me use my first name only at ratbags.com

"jandew6" wrote:


"Peter Bowditch" THE LIAR AND wrote:
"Jan Drew" wrote:


"John Palmer" wrote in message
...
On Mon, 12 Mar 2007 11:33:40 GMT, "Jeff" wrote:


That's true of any drugs. I have read one of Peter Breggin's books.
He
clearly doesn't, IMHO, understand ADHD.

ROTFLOL.

He tells it like it is.

He tells it like he sees it. And what he sees is the royalties he gets
when
his books sell.

He does neither. He's a liar.

GOD BLESS DR BREGGIN.


GOD BLESS DR BREGGIN.
And send him money.

snip nonsense
--
Peter Bowditch aa #2243
The Millenium Project http://www.ratbags.com/rsoles
Australian Council Against Health Fraud http://www.acahf.org.au
Australian Skeptics http://www.skeptics.com.au
To email me use my first name only at ratbags.com

On Mar 13, 8:02 am, Mark Probert wrote:
Caitriona Mac Fhiodhbhuidhe wrote:
On Mar 12, 10:42 am, Mark Probert
wrote:
Jeff wrote:

"Mark Probert" wrote in message
news:81eJh.4039$0W5.287@trndny05...
...
What makes one group who calls themselves "Christian" more "Christian"
than another group?
Caring

Hey, Mark, thanks for the link. Bible studies can be a challenge when
the brain won't slow down enough. I've found that I can focus better
in our adult Sunday school class if I'm spinning with my drop
spindle. It keeps my hands busy enough that I can focus on the
discussion without worrying about something to fiddle with. I'll have
to see if there's something in the Bible Studies link of that site
that would work for me.

Glad to help. How are the kids and the kids?


It's a bit of the BP's vs the ADDers atm. :-(

There are two claddaghs sitting side-by-side on my monitor stand,
instead of on the hands they should be on.


Watch your email for a link to some pics of our trip. We are still
sorting out 900 digital pictures, enhancing and cropping.


I'll look for it.

Kitten

"Peter Bowditch" wrote in message
...
"jandew6" wrote:


"Peter Bowditch" wrote :
"Jan Drew" wrote:



snip unsubstantiated defamation

Repeated lie.
--
Peter Bowditch

Typical liar.

snip unsubstantiated defamation

Repeated lie.
--
Peter Bowditch

"Jan Drew" wrote:


"Peter Bowditch" wrote in message
.. .
"jandew6" wrote:


"Peter Bowditch" wrote :
"Jan Drew" wrote:



snip unsubstantiated defamation

Repeated lie.

I stand corrected. What I snipped was not simply "unsubstantiated
defamation", it was also a repeated lie. Thank you for pointing this
out, Jan, and I hope that the next time that someone repeats the lie
you will criticise them directly rather than waiting for me to do it
and then agreeing with me.

--
Peter Bowditch

Typical liar.

snip unsubstantiated defamation

Repeated lie.

Thanks again for the support, Jan. People should not be able to repeat
lies.

--
Peter Bowditch

--
Peter Bowditch aa #2243
The Millenium Project http://www.ratbags.com/rsoles
Australian Council Against Health Fraud http://www.acahf.org.au
Australian Skeptics http://www.skeptics.com.au
To email me use my first name only at ratbags.com

On Mar 10, 8:24 pm, "Jan Drew" wrote:
http://www.mmdnewswire.com/content/view/1383/5/

THE ATTENTION DEFICIT DILEMMA AND OUR CHILDREN

March 7, 2007 Flower Mound, Texas. Recently, the Food and Drug
Administration (FDA) announced additional precautions concerning drugs
prescribed for Attention Deficit Disorder (ADD) and Attention Deficit
Hyperactivity Disorder (ADHD). Apparently, the government agency is working
closely with drug manufacturers to develop new patient medication
guidelines, and the FDA is calling for enhanced product labeling about the
potential adverse affects. Among problems cited, adults with serious heart
ailments, and those with other risk factors were experiencing sudden death
in reports reviewed by the agency.

The FDA also cited a slightly increased risk (1 of 1000) for drug related
psychiatric adverse events such as hearing voices, unexplainable suspicion,
and becoming manic. This was also evident in patients without previous
psychiatric problems.

Dr. Steven B. DavidSon, the author of the Christ-based Counseling volumes,
and Director of the National Association of Certified Christ-based
Counselors explains that these are not new revelations. "Actually, it is
about time the Federal Government elevated the awareness about drugs used
for ADD and ADHD."

Given our Christ-based perspective, attention deficit has been with us since
the first human beings where distracted. No doubt, there are persons who
suffer severely, but parties need to seriously assess the risk-reward factor
when considering the use of psychiatric drugs, particularly with children."
DavidSon alludes to the work by authors Peter R Breggin and David Cohen in
their book, Your Drug Could Be Your Problem. How and Why to Stop Taking
Psychiatric Medications.

While the research concerning ADD and ADHD has been around for decades,
DavidSon said he observed increased diagnoses in the mid-1980s and into the
1990s. "Initially, young boys were primarily the ones diagnosed followed by
girls and then adults. I cannot speak for other practices, but I noted the
growth was consistent with the expansion and development of video games.
Additionally, you must consider the contributions of poor diet and
faulty-discipline to ADHD. Diet and discipline have declined over time. It
is a matter of record that our children have higher incidents of obesity,
and don't mention the condition of child-discipline in the nation."

DavidSon also briefly addressed conditions where parents are encouraged to
induce drugs where children are inattentive. Some parents lean toward
medicinal therapy with the hope of improving grade performance. "When asked
by parents about my Christ-based perspective, I suggest a simple observation
such as 'how long can your child play a favorite video game?' If the child
can play for extended periods of time and maintain scoring, the problem may
be an educational-delivery deficit, and not an attention functioning
deficit." DavidSon is adamant that people need to ponder these observations
with their physicians before determining to use drug therapy. He adds,
"Several years ago, I allowed my child to record satisfactory grade
performance as opposed to inducing drugs as recommended by an educational
psychologist. Thank God! Notwithstanding the short-term successes of
these drugs, one in one-thousand does not sound like high-risk for an
adverse drug reaction until your child is the one. Moreover, when the
adverse reaction is related to brain functioning, or gives a child the
impression that drugs should be administered for the slightest mental
slippage, I decided my child would catch-up with the head-of-the-class
later. It is a dilemma indeed trying to convince young people not to use
recreational drugs to improve their social acceptance and fun when their
parents encouraged drug-use for their educational acceptance. As Jesus would
say, 'those who have an ear, let them hear.'"

[to which I say AMEN!].

Hi
Are you aware of the amount of toxic chemicals used in our homes
everyday? Did you know that our home and personal care products are
harming our children? Cleaning products can harm our children even
before they are born. THE 10 MOST COMMON CLEANING PRODUCTS USED BY
PREGNANT WOMAN
BLEACH
CARPET CLEANER
AIR FRESHENERS
PAINT STRIPPER
PAINT OR VARNISH
DRY CLEANING FLUID
TURPENTINE
WINDOW CLEANER
AERSOLS
PESTICIDES/INSECTICIDES

CANCER-CAUSING CHEMICALS FOUND IN CHILDRENS BATH PRODUCTS:
Petrochemical has been found in dozens of children's bath products and
adult personal care products. Some are listed below.
Disney Clean as Can Bee Hair & Body Wash
Gerber Grins & Giggles Gentle & Mild Aloe Vera Baby Shampoo
Huggies Baby Wash Shea Butter
Johnson's Head to Toe Baby Wash
Clariol Herbal Essences Rainforest Flowers Shampoo
Olay Complete Body Wash with Vitamins

If you are interested in hearing more information contact me at
I can email you more info.
Vi

wrote in message
oups.com...
THE 10 MOST COMMON CLEANING PRODUCTS USED BY
PREGNANT WOMAN
AIR FRESHENERS
PAINT STRIPPER
PAINT OR VARNISH
DRY CLEANING FLUID
TURPENTINE
WINDOW CLEANER
AERSOLS
PESTICIDES/INSECTICIDES


Did you even read what you posted [and probably didn't author] in your
efforts to spam? Most of those items are not cleaning products, and a few
of them, such as dry cleaning fluids, are not commonly used in the home at
all. Ah, but you won't read this message because you are on to other
seemingly fertile spamming grounds by now. Sheesh!

-Aula